In 2016, Canada became the sixth country (and 14th jurisdiction) to decriminalize physician-assisted death (PAD). In its unanimous ruling, the Supreme Court of Canada (SCC) stated that the prohibition on assisted death violated the Canadian Charter of Rights and Freedoms "right to life, liberty, and security of the person" with emphasis on personal autonomy and dignity. 1, 2 Subsequent federal legislation legalized both forms of PAD (voluntary euthanasia and assisted suicide) and included a set of eligibility criteria as well as several safeguards. 3 In a poll conducted following the SCC ruling, a majority of Canadians supported the decision with 78% of those polled in favor, 60% "strongly" so and only 9% strongly opposed. 4 While there is ongoing discussion regarding the regulations of the Canadian legislation, public support remains high with 90% of Canadians believing some form of assisted death should be allowed. 5 This is in keeping with high levels of public support in other countries including the United States (64%), Britain (84%), and much of Western Europe. 6, 7 Notably, in all jurisdictions where PAD has been legalized requests for, and actual cases of, PAD have increased the longer the practices have been in place. 6 While breakdown between types is not readily available, neurodegenerative disorders are the second ranking disease entity (after cancer) in those accessing PAD worldwide (6%-11% of all reported cases). 6 Interim data from Canada, which has one of the highest prevalences of multiple sclerosis (MS) in the world, 8 suggest an even higher proportion of neurodegenerative disease (23%) in those patients who obtain PAD. 9 Studies in persons with MS reveal that close to one-third have thought about assisted suicide as an option for themselves. 10 In a recent survey using hypothetical situations, approximately 7% of respondents with MS indicated they would consider PAD if faced with any of the situations described, with 65% indicating they would consider PAD if experiencing unbearable pain and 50% indicating they would consider PAD if they were unable to enjoy anything that made life worth living. 11 This is in keeping with data from jurisdictions where PAD has been legalized with loss of ability to engage in activities making life enjoyable cited as the second highest end of life concern in those seeking PAD, after loss of autonomy. 6 In its ruling, the SCC dismissed concerns of a "slippery slope" for vulnerable persons 12 believing that "properly designed and administered safeguards (are) capable of protecting vulnerable people from abuse and error." 13 While not identical, all jurisdictions where PAD is permitted have regulations regarding its practice including how it is to be applied, requirements to be met to be eligible and measures to limit possible abuse. 13 Despite concerns that vulnerable persons (including those with disability) may be pressured to pursue PAD, data from jurisdictions where PAD has been legalized indicate no evidence that these persons have been receiving PAD at higher rates than the general population or that PAD has harmed their best interests. 6, 14 Notably, data also reveal no evidence that the option of PAD undermines end-of life care 14 and in fact would suggest improved support and funding of endof-life services following the legalization of PAD. 15 In the initial court decision leading up to the SCC case, the judge reasoned that there was no ethical distinction between PAD and other end-of-life practices such as withholding or withdrawing life-sustaining therapies or administering palliative sedation. 16 Reasoning also concluded that the law already allows competent individuals to refuse or withdraw life-sustaining therapies with the prohibition on PAD seen as an infringement of this right. 12 In practice, decisions to withhold or withdraw life-sustaining therapies are often made by substitute decision makers despite multiple concerns regarding this process. 15 In most jurisdictions where PAD has been legalized, PAD is only provided to capable adults and is not permitted via substitute decision makers or via advance directive. 6 Given this, it has been questioned as to why should we allow persons to choose a passive death but not an active death? 15 The majority of jurisdictions that permit PAD require persons to have a medical condition which causes enduring suffering that is intolerable to them. 6, 13 Suffering and quality of life are subjective and something for individuals to decide for themselves including at what point such life has deteriorated below a level they consider acceptable. 14 For some persons they do not want to wait for a complication to end their suffering and they reach a threshold where they are willing to forgo life in the interest of comfort. 15 Few would argue that it is a physician's role to ease suffering. When suffering cannot be relieved by other means, many see PAD as an extension of a physician's duty to care 15 and believe that medicine should aim to accommodate the wishes of all patients with a refusal to allow PAD being an act of unacceptable paternalism. 14 
MS
is as yet incurable and can lead to profound physical disability leading to dependence on others, and increased mortality. 17 Persons with MS may experience a high symptom burden including severe pain, and therapies are often inadequate to completely alleviate their suffering. Weighing risks and benefits of therapy is common place for those with MS. Provided they meet eligibility criteria and retain capacity to make medical decisions for themselves, the option of PAD should be available to persons with MS.
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